You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lenalidomide

Showing 51 - 75 of 662
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
Aug 19, 2022

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Myeloma
  • Poitiers, France
    CHU Poitiers
Sep 5, 2022

Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 10, 2023

DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to DLBCL Trial

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 5, 2023

Large B-Cell Lymphoma, DLBCL Trial (Tafasitamab, Lenalidomide)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Jun 17, 2022

Multiple Myeloma Trial in Busan (Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
Mar 31, 2022

Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

Not yet recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +2 more
  • Biopsy
  • +8 more
  • Duarte, California
    City of Hope Medical Center
May 15, 2023

Smouldering Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Lenalidomide)

Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
Mar 22, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma Trial in New Haven, New Brunswick, Providence (Mosunetuzumab,

Recruiting
  • Follicular Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +2 more
Jul 14, 2022

Mantle Cell Lymphoma, Untreated Trial in United States (Lenalidomide, R-CHOP, high-dose cytarabine (HIDAC))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 17, 2022

Multiple Myeloma Trial in Rochester (Daratumumab, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Rochester, New York
    University of Rochester Medical Center
Jul 8, 2022

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,

Active, not recruiting
Has Results
  • Stage I Multiple Myeloma
  • +2 more
  • Chicago, Illinois
  • +4 more
Sep 3, 2022

Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in United States (Romidepsin, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
  • Hartford, Connecticut
  • +6 more
Jan 3, 2023

Multiple Myeloma Trial in United States (lenalidomide)

Completed
Has Results
  • Multiple Myeloma
  • lenalidomide
  • Stamford, Connecticut
  • +10 more
Apr 12, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Melbourne, Australia
  • +13 more
Feb 7, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Biopsy
  • +10 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 9, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023

Mantle Cell Lymphoma Trial in United States (lenalidomide, rituximab)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • lenalidomide
  • rituximab
  • Tampa, Florida
  • +3 more
Mar 26, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Sacramento (Lenalidomide)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Lenalidomide
  • Sacramento, California
    University of California Davis
Mar 8, 2022

Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Dec 28, 2022

Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Active, not recruiting
  • Plasma Cell Myeloma
  • Daratumumab
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Acute Myeloid Leukemia Trial in Chapel Hill (Lenalidomide)

Completed
  • Acute Myeloid Leukemia
  • Lenalidomide
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill - Lineberger Compreh
Jan 25, 2022

Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 15, 2022

Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

Recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Durvalumab
  • +2 more
  • Duarte, California
  • +3 more
Jan 12, 2023